Anthony C Toy, OD
Optometry · Union City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Toy’s office at (510) 675-4010 to ask if they take your plan before you enroll.
State licence records
1 licence
- Washington OD.OD.00004083Optometrist License · since 2006 · expires 2008-05-29ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Medicaid work
$32,111 in 2024
Medicaid paid $32,111 for 751 billed services this clinician did in 2024, up to 52 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 163 | $15,378 |
| INTRM OPH EXAM NEW PATIENT | 156 | $9,653 |
| DETERMINATION REFRACTIVE STATE | 432 | $7,080 |
| 2024 | 751 | 3 | 52 | $32,111 |
| 2023 | 488 | 3 | 36 | $259 |
| 2022 | 367 | 3 | 28 | $274 |
| 2021 | 278 | 3 | 29 | $60 |
| 2020 | 33 | 1 | 21 | $7 |
| 2019 | 268 | 2 | 27 | $51 |
| 2018 | 355 | 3 | 28 | $59 |
See the largest Medicaid services in earlier years
2023
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 100 | $152 |
| DETERMINATION REFRACTIVE STATE | 277 | $70 |
| INTRM OPH EXAM NEW PATIENT | 111 | $37 |
2022
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 37 | $171 |
| DETERMINATION REFRACTIVE STATE | 250 | $54 |
| INTRM OPH EXAM NEW PATIENT | 80 | $49 |
2021
| DETERMINATION REFRACTIVE STATE | 237 | $60 |
| INTRM OPH EXAM NEW PATIENT | 27 | $0 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 14 | $0 |
2020
| DETERMINATION REFRACTIVE STATE | 33 | $7 |
2019
| DETERMINATION REFRACTIVE STATE | 229 | $30 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 39 | $20 |
2018
| DETERMINATION REFRACTIVE STATE | 251 | $30 |
| INTRM OPH EXAM NEW PATIENT | 12 | $30 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 92 | $0 |
Drugs they prescribed that Part D paid
$4,756
Pharmacies billed $4,756 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 108) in 2024. At or below the middle of the specialty; the typical optometry clinician is at 0%.
76 generic and 32 brand-name prescriptions · $4,756 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cyclosporine | 27 | $2,990 | $111 |
| Latanoprost | 63 | $997 | $16 |
Year by year
| 2024 | 108 | 52 | 0% (0) | 30% | $4,756 |
| 2023 | 131 | 54 | 0% (0) | 34% | $5,388 |
| 2022 | 100 | 39 | 0% (0) | 30% | $8,318 |
| 2021 | 86 | 33 | 0% (0) | 23% | $7,855 |
| 2020 | 93 | 33 | 0% (0) | 16% | $10,776 |
| 2019 | 99 | 48 | 0% (0) | 23% | $11,973 |
| 2018 | 65 | 36 | 0% (0) | None | $3,695 |
| 2017 | 55 | 23 | 0% (0) | 49% | $4,615 |
| 2016 | 74 | 16 | 0% (0) | 72% | $13,067 |
| 2015 | 34 | 15 | 0% (0) | None | $3,249 |
| 2014 | 41 | 20 | 0% (0) | 49% | $2,218 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Cyclosporine | 33 | $3,315 | $100 |
| Latanoprost | 48 | $766 | $16 |
| Prednisolone Acetate | 12 | $628 | $52 |
| Olopatadine | 13 | $293 | $23 |
2022: 3 drugs
| Cequa | 15 | $5,647 | $376 |
| Latanoprost | 31 | $564 | $18 |
| Olopatadine | 19 | $503 | $26 |
2021: 3 drugs
| Cequa | 14 | $6,316 | $451 |
| Latanoprost | 31 | $591 | $19 |
| Olopatadine | 16 | $263 | $16 |
2020: 4 drugs
| Restasis | 13 | $8,111 | $624 |
| Latanoprost | 44 | $1,027 | $23 |
| Dorzolamide-Timolol | 11 | $292 | $27 |
| Olopatadine | 17 | $288 | $17 |
2019: 2 drugs
| Restasis | 15 | $9,874 | $658 |
| Latanoprost | 44 | $984 | $22 |
2018: 1 drug
| Latanoprost | 29 | $726 | $25 |
2017: 2 drugs
| Latanoprost | 15 | $421 | $28 |
| Timolol Maleate | 11 | $136 | $12 |
2016: 3 drugs
| Restasis | 22 | $9,469 | $430 |
| Latanoprost | 13 | $166 | $13 |
| Timolol Maleate | 13 | $99 | $8 |
2014: 1 drug
| Latanoprost | 11 | $118 | $11 |
Money from drug and device companies
$148 in 2025
| 2025 | 1 | 1 | None | $148 |
| 2024 | 2 | 2 | None | $218 |
| 2023 | 2 | 2 | None | $247 |
| 2021 | 1 | 1 | None | $112 |
| 2020 | 1 | 1 | None | $17 |
| 2019 | 1 | 1 | None | $142 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Tarsus Pharmaceuticals | None | $148 | 1 payment
|
See the published payment
| Tarsus Pharmaceuticals | Meals · 2025-10-24 | None | $148 |
See earlier years (2024, 2023, 2021, 2020, 2019)
2024: $218
| Amgen | Tepezza | $122 | 1 payment
|
| Johnson & Johnson Vision Care | Acuvue | $96 | 1 payment
|
2023: $247
| Biotissue Holdings | Prokera | $150 | 1 payment
|
| CooperVision | Paragon Crt | $97 | 1 payment
|
2021: $112
| Johnson & Johnson Vision Care | Acuvue | $112 | 1 payment
|
2020: $17
| Carl Zeiss Meditec | None Specified | $17 | 1 payment
|
2019: $142
| Allergan | Ozurdex | $142 | 1 payment
|
Professional record
- NPI
- 1063564805
- Licence
- CA 13364TLG, WA OD4083TXWashington OD.OD.00004083: Expired
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 152W00000X (152W00000X)
- Mailing address
- 10680 S De Anza Blvd, Suite C, Cupertino, CA, 95014
- NPI first listed
- 2007-01-18
- NPI last updated
- 2022-01-03
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.